170 related articles for article (PubMed ID: 32958685)
1. Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B.
Alvarez de Cienfuegos A; Cheung LH; Mohamedali KA; Whitsett TG; Winkles JA; Hittelman WN; Rosenblum MG
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958685
[TBL] [Abstract][Full Text] [Related]
2. Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.
Zhou H; Mohamedali KA; Gonzalez-Angulo AM; Cao Y; Migliorini M; Cheung LH; LoBello J; Lei X; Qi Y; Hittelman WN; Winkles JA; Tran NL; Rosenblum MG
Mol Cancer Ther; 2014 Nov; 13(11):2688-705. PubMed ID: 25239934
[TBL] [Abstract][Full Text] [Related]
3. Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B.
Cheung LH; Zhao Y; Alvarez-Cienfuegos A; Mohamedali KA; Cao YJ; Hittelman WN; Rosenblum MG
J Exp Clin Cancer Res; 2019 Jul; 38(1):332. PubMed ID: 31362764
[TBL] [Abstract][Full Text] [Related]
4. Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neu.
Cao Y; Mohamedali KA; Marks JW; Cheung LH; Hittelman WN; Rosenblum MG
Mol Cancer Ther; 2013 Jun; 12(6):979-91. PubMed ID: 23493312
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agents.
Liu Y; Cheung LH; Hittelman WN; Rosenblum MG
Mol Cancer Ther; 2003 Dec; 2(12):1341-50. PubMed ID: 14707275
[TBL] [Abstract][Full Text] [Related]
6. A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.
Qian X; Shi Z; Qi H; Zhao M; Huang K; Han D; Zhou J; Liu C; Liu Y; Lu Y; Yuan X; Zhao J; Kang C
Theranostics; 2019; 9(25):7616-7627. PubMed ID: 31695790
[TBL] [Abstract][Full Text] [Related]
7. EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.
Oberoi P; Jabulowsky RA; Bähr-Mahmud H; Wels WS
PLoS One; 2013; 8(4):e61267. PubMed ID: 23573299
[TBL] [Abstract][Full Text] [Related]
8. The functionalized human serine protease granzyme B/VEGF₁₂₁ targets tumor vasculature and ablates tumor growth.
Mohamedali KA; Cao Y; Cheung LH; Hittelman WN; Rosenblum MG
Mol Cancer Ther; 2013 Oct; 12(10):2055-66. PubMed ID: 23858102
[TBL] [Abstract][Full Text] [Related]
9. Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropin.
Kanatani I; Lin X; Yuan X; Manorek G; Shang X; Cheung LH; Rosenblum MG; Howell SB
Cancer Chemother Pharmacol; 2011 Oct; 68(4):979-90. PubMed ID: 21327682
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: directed apoptotic events in vascular endothelial cells.
Liu Y; Cheung LH; Thorpe P; Rosenblum MG
Mol Cancer Ther; 2003 Oct; 2(10):949-59. PubMed ID: 14578460
[TBL] [Abstract][Full Text] [Related]
11. Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity.
Liu Y; Zhang W; Niu T; Cheung LH; Munshi A; Meyn RE; Rosenblum MG
Neoplasia; 2006 Feb; 8(2):125-35. PubMed ID: 16611405
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cells.
Zhou H; Marks JW; Hittelman WN; Yagita H; Cheung LH; Rosenblum MG; Winkles JA
Mol Cancer Ther; 2011 Jul; 10(7):1276-88. PubMed ID: 21586630
[TBL] [Abstract][Full Text] [Related]
13. Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition.
Dälken B; Giesübel U; Knauer SK; Wels WS
Cell Death Differ; 2006 Apr; 13(4):576-85. PubMed ID: 16179940
[TBL] [Abstract][Full Text] [Related]
14. Granzyme B-loaded, cell-selective penetrating and reduction-responsive polymersomes effectively inhibit progression of orthotopic human lung tumor in vivo.
Yang W; Wei Y; Yang L; Zhang J; Zhong Z; Storm G; Meng F
J Control Release; 2018 Nov; 290():141-149. PubMed ID: 30312720
[TBL] [Abstract][Full Text] [Related]
15. Surface charge-modification prevents sequestration and enhances tumor-cell specificity of a recombinant granzyme B-TGFα fusion protein.
Jabulowsky RA; Oberoi P; Bähr-Mahmud H; Dälken B; Wels WS
Bioconjug Chem; 2012 Aug; 23(8):1567-76. PubMed ID: 22759275
[TBL] [Abstract][Full Text] [Related]
16. The anti-Fn14 antibody BIIB036 inhibits tumor growth in xenografts and patient derived primary tumor models and enhances efficacy of chemotherapeutic agents in multiple xenograft models.
Michaelson JS; Kelly R; Yang L; Zhang X; Wortham K; Joseph IB
Cancer Biol Ther; 2012 Jul; 13(9):812-21. PubMed ID: 22669574
[TBL] [Abstract][Full Text] [Related]
17. A Microfluidic Platform for Single Cell Fluorometric Granzyme B Profiling.
Briones JC; Espulgar WV; Koyama S; Yoshikawa H; Park J; Naito Y; Kumanogoh A; Tamiya E; Takamatsu H; Saito M
Theranostics; 2020; 10(1):123-132. PubMed ID: 31903110
[TBL] [Abstract][Full Text] [Related]
18. EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo.
Chen J; Ouyang J; Chen Q; Deng C; Meng F; Zhang J; Cheng R; Lan Q; Zhong Z
ACS Appl Mater Interfaces; 2017 Jul; 9(28):24140-24147. PubMed ID: 28675028
[TBL] [Abstract][Full Text] [Related]
19. The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock.
Mendez-Barbero N; Yuste-Montalvo A; Nuñez-Borque E; Jensen BM; Gutiérrez-Muñoz C; Tome-Amat J; Garrido-Arandia M; Díaz-Perales A; Ballesteros-Martinez C; Laguna JJ; Beitia JM; Poulsen LK; Cuesta-Herranz J; Blanco-Colio LM; Esteban V
J Allergy Clin Immunol; 2020 Feb; 145(2):583-596.e6. PubMed ID: 31679818
[TBL] [Abstract][Full Text] [Related]
20. CD44-targeted vesicles encapsulating granzyme B as artificial killer cells for potent inhibition of human multiple myeloma in mice.
Zhong Y; Meng F; Zhang W; Li B; van Hest JCM; Zhong Z
J Control Release; 2020 Apr; 320():421-430. PubMed ID: 32027936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
